Lv5
1170 积分 2020-11-13 加入
Gastric cancer
3个月前
已完结
Low-dose lenvatinib and anti-programmed cell death protein-1 combination therapy in patients with heavily pre-treated recurrent ovarian and endometrial cancer: a pilot study
5个月前
已关闭
Gastric cancer
5个月前
已完结
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer
5个月前
已完结
The next generation of immunotherapies for lung cancers
5个月前
已完结
Low-dose lenvatinib plus toripalimab for patients with platinum-resistant recurrent ovarian cancer: preliminary results from a multicenter, phase II trial (NCT06241105)
5个月前
已关闭
Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial
5个月前
已完结
First-line treatment with a combination of immunotherapy, anti-EGFR monoclonal antibodies, and chemotherapeutics for unresectable left KRAS/BRAF wild-type microsatellite-stable colorectal cancer: a case report
6个月前
已完结
Targeting B and T lymphocyte attenuator in cancer immunotherapy
6个月前
已关闭
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
6个月前
已完结
皖公网安备34019202002308
